Exponent (NASDAQ:EXPO) Issues Quarterly Earnings Results

Posted by Brenda Bartman on Jul 30th, 2026

Exponent (NASDAQ:EXPO – Get Free Report) announced its earnings results on Thursday. The business services provider reported $0.60 earnings per share for the quarter, beating the consensus estimate of $0.55 by $0.05, FiscalAI reports. Exponent had a return on equity of 27.94% and a net margin of 18.07%.The firm had revenue of $171.61 million for the quarter, compared to the consensus estimate of $144.99 million. During the same quarter in the previous year, the business earned $0.52 EPS. The firm’s revenue for the quarter was up 12.0% on a year-over-year basis.

Here are the key takeaways from Exponent’s conference call:

Strong second-quarter execution: Net revenue increased 12% to $148.9 million, EBITDA rose 16% with margin expanding to 28.7%, and diluted EPS grew 15% to $0.60. Results benefited from higher utilization and a large user research engagement.
Exponent raised its 2026 outlook, now expecting 9%–10% net revenue growth and EBITDA margins of 27.8%–28.1%; third-quarter net revenue is projected to grow 8%–10%.
Demand for AI-enabled products is expanding Exponent’s proactive user research work across consumer electronics, wearables, medical devices, and other technologies, while reactive opportunities are growing in advanced driver-assistance systems and data-center infrastructure.
The board authorized an additional $50 million share-repurchase capacity after $211 million of buybacks over the past 12 months, alongside $61 million in dividends; management expects more than $100 million of free cash flow in the second half of 2026.
Management indicated that the large user research study that represented approximately 4% of second-quarter net revenue moderated late in the quarter and is expected to contribute about 2% of net revenue for the remainder of the year, while fourth-quarter utilization will face normal seasonal pressure.

Exponent Price Performance

Shares of NASDAQ:EXPO traded down $1.28 on Thursday, reaching $64.57. 775,014 shares of the company traded hands, compared to its average volume of 503,649. The stock has a market capitalization of $3.13 billion, a PE ratio of 30.03 and a beta of 0.72. The company’s 50 day moving average is $59.82 and its 200-day moving average is $65.22. Exponent has a fifty-two week low of $51.91 and a fifty-two week high of $81.95.

Insider Buying and Selling

In other Exponent news, VP Joseph Sala sold 2,066 shares of the firm’s stock in a transaction dated Wednesday, May 13th. The shares were sold at an average price of $56.66, for a total value of $117,059.56. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Bradley A. James sold 2,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 26th. The shares were sold at an average price of $57.47, for a total transaction of $114,940.00. Following the completion of the sale, the vice president owned 1,105 shares of the company’s stock, valued at approximately $63,504.35. This trade represents a 64.41% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 15,324 shares of company stock worth $855,019. Company insiders own 1.60% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the business. UMB Bank n.a. raised its position in Exponent by 54.8% during the fourth quarter. UMB Bank n.a. now owns 904 shares of the business services provider’s stock valued at $63,000 after buying an additional 320 shares during the period. Kestra Advisory Services LLC purchased a new position in Exponent during the 4th quarter valued at about $78,000. nVerses Capital LLC purchased a new position in Exponent during the 4th quarter valued at about $218,000. FORA Capital LLC acquired a new position in shares of Exponent in the 2nd quarter valued at about $228,000. Finally, Elevation Point Wealth Partners LLC acquired a new position in shares of Exponent in the 4th quarter valued at about $234,000. Hedge funds and other institutional investors own 92.37% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently commented on EXPO. JPMorgan Chase & Co. lowered their price target on Exponent from $95.00 to $80.00 and set an “overweight” rating on the stock in a report on Friday, May 15th. UBS Group reaffirmed a “neutral” rating and issued a $75.00 price objective on shares of Exponent in a report on Tuesday, June 2nd. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Exponent in a research note on Friday, July 17th. Two analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $77.50.

Get Our Latest Stock Analysis on Exponent

About Exponent

(Get Free Report)

Exponent, Inc (NASDAQ: EXPO) is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company’s expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.

Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.